Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

Sounding BoardFree Preview

Today's FDA

List of authors.
  • Eve E. Slater, M.D.

In 1992, the passage of the Food and Drug Administration (FDA) Prescription Drug User Fee Act and, in 1997, the FDA Modernization Act resulted in an 85 percent increase in the number of employees at the FDA and in more efficient processes for the approval of drugs. In this article, the author identifies the remaining challenges facing the FDA. She contends that the FDA should improve its post-marketing surveillance, facilitate communication of information about the risks of drugs and devices, and contribute to efforts to control the cost of drugs.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Dr. Slater served as assistant secretary for health at the Department of Health and Human Services from January 2002 until her resignation in February 2003; the FDA was not in her purview in this post. She reports serving on the board of directors of Vertex Pharmaceuticals and having received consulting fees from Celgene Cellular Therapeutics Division, AnorMED, and Warburg Pincus.

Print Subscriber? Activate your online access.